CervoMed Inc. (CRVO)

CervoMed Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	8.24	9	7.79	10.11	37.31
Short-Term Investments	12.63	29.92	-	12.41	-
Cash & Short-Term Investments	20.86	38.92	7.79	22.52	37.31
Cash Growth	-46.39%	399.46%	-65.40%	-39.64%	101.53%
Other Receivables	0.43	2.25	0.92	-	-
Total Trade Receivables	0.43	2.25	0.92	-	-
Other Current Assets	1.59	1.91	1.26	0.11	0.51
Total Current Assets	22.88	43.08	9.96	22.64	37.82
Other Long-Term Assets	-	-	0.01	-	0.02
Total Assets	22.88	43.08	9.97	22.64	37.84
Accounts Payable	1.45	1.51	0.66	1.13	0.95
Accrued Expenses	3.2	2.37	1.93	1.29	1.98
Total Current Liabilities	4.66	3.88	2.6	2.42	2.93
Total Liabilities	4.66	3.88	2.6	2.42	2.93
Common Stock	0.01	0.01	0.01	0	0
Additional Paid-in Capital	115.91	109.87	61.81	165.85	164.92
Accumulated Other Comprehensive Income	0.01	0.06	-	-0.04	-
Retained Earnings	-97.7	-70.73	-54.44	-145.6	-130.01
Shareholders' Equity	18.22	39.2	7.38	20.22	34.91
Total Liabilities & Equity	22.88	43.08	9.97	22.64	37.84
Net Cash (Debt)	20.86	38.92	7.79	22.52	37.31
Net Cash Growth	-46.39%	399.46%	-65.40%	-39.64%	103.16%
Net Cash Per Share	2.31	4.82	2.93	43.47	51.99
Book Value	18.22	39.2	7.38	20.22	34.91
Book Value Per Share	2.02	4.86	2.77	39.02	48.64
Tangible Book Value	18.22	39.2	7.38	20.22	34.91
Tangible Book Value Per Share	2.02	4.86	2.77	39.02	48.64

Updated Mar 13, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q